Genetic Testing Market – Forecasts from 2016 to 2021
DESCRIPTION Genetic testing refers to a process of analysis of human DNA. Growing need for early detection and prevention of various genetic diseases is the key driver of the global genetic testing market. Rising implementation of personalized medicine applications to treat chronic diseases enhances the demand for HLA typing and DNA identification for therapy, thereby positively impacting the genetic testing market growth. Others drivers include supportive government initiatives, increased R&D activities in the genetic testing field, and innovation of new techniques for genetic testing. In the coming years, the growing demand for newborn and prenatal screening to detect congenital abnormalities will provide a great opportunity for the expansion of the genetic testing market. The mushrooming need for genetic testing to determine patient’s health at different stages of diseases development will further propel the market growth in the forthcoming years. North America holds the largest share of global genetic testing market owing to technological advancements, rising prevalence of genetic diseases and high quality of infrastructure to support the genetic testing industry in the region. However, emerging economies hold good potential for the growth of genetic testing market due to factors such as rising patient pool, more government funding supporting the investment in the industry and growing awareness regarding the technology. APAC region will witness the fastest market growth owing to rising aging population, rising purchasing power, and technological advancements in the region. However, the high cost of genetic testing coupled with unclear reimbursement structure, lack of skilled personnel, and lack of regulations in the market will restrain the growth of this market during the forecast period. Research Methodology Firstly, the report provides a brief introduction of the market and deals with detailed research methodology for calculating market size and forecasts, secondary data sources used and the primary inputs which were taken for data validation. This section also outlines various segmentation which has been covered as part of the report.
Genetic Testing Market – Forecasts from 2016 to 2021
Market Dynamics Next, the section provides comprehensive market dynamics through an overview section along with growth drivers, challenges, and opportunities which exist in the current market. This section of the report also provides supplier and industry outlook as a whole; key industry, global and regional regulations which are determining the market growth and a brief technological aspect of Genetic Testing. Complete industry analysis has also been covered by Porter’s five forces model as a part of this report section. Segmentation Thirdly, Genetic Testing market has been segmented on the basis of type, application, and Geography as follows: By Type o Molecular o Chromosomal o Biochemical By Application o Conformal Diagnosis o Presymptomatic Testing o Parental Diagnostic Screening o Newborn Screening o Preimplantation genetic diagnosis o Carrier Screening o Parental Testing By Geography o
Americas North America
US
Genetic Testing Market – Forecasts from 2016 to 2021
Canada
Mexico
Others
South America
Brazil
Others
o Europe Middle East and Africa Europe
United Kingdom
Germany
France
Others
Middle East and Africa o Asia Pacific Japan China India Others
Market Players Finally, competitive intelligence section deals with major players in the market, their market shares, growth strategies, products, financials, and recent investments among others. Key industry players profiled as part of this section are 23 & Me, Abbott Molecular, Roche Holding, Biocartis, Cepheid, Illumina, Luminex Corporation, Sequenom, and Transgenomic among others.
Genetic Testing Market – Forecasts from 2016 to 2021
TABLE OF CONTENTS 1. Introduction 2. Research Methodology 3. Executive Summary 4. Market Dynamics 4.1. Market Overview and Segmentations 4.2. Drivers 4.3. Restraints 4.4. Opportunities 4.5. Supplier Outlook 4.6. Industry Outlook 4.7. Porter’s 5 Forces Analysis 4.8. Industry Value Chain Analysis 5. Genetic Testing Market Forecast by Type (US$ billion) 5.1. Molecular 5.2. Chromosomal 5.3. Biochemical 6. Genetic Testing Market Forecast by Application (US$ billion) 6.1. Conformal Diagnosis 6.2. Presymptomatic Testing 6.3. Parental Diagnostic Screening 6.4. Newborn Screening 6.5. Preimplantation genetic diagnosis 6.6. Carrier Screening 6.7. Parental Testing 7. Genetic Testing Market Forecast by Geography (US$ billion) 7.1. Americas 7.1.1. North America 7.1.1.1. US 7.1.1.2. Canada 7.1.1.3. Mexico 7.1.1.4. Others Genetic Testing Market – Forecasts from 2016 to 2021
7.1.2. South America 7.1.2.1. Brazil 7.1.2.2. Others 7.2. Europe Middle East and Africa 7.2.1. Europe 7.2.1.1. United Kingdom 7.2.1.2. Germany 7.2.1.3. France 7.2.1.4. Others 7.2.2. Middle East and Africa 7.3. Asia Pacific 7.3.1. Japan 7.3.2. China 7.3.3. India 7.3.4. Others 8. Competitive Intelligence 8.1. Investment Analysis 8.2. Recent Deals 8.3. Strategies of Key Players 9. Company Profiles 9.1. 23 & Me 9.2. Abbott Molecular 9.3. Roche Holding 9.4. Biocartis 9.5. Cepheid 9.6. Illumina 9.7. Luminex Corporation 9.8. Sequenom 9.9. Transgenomic
Genetic Testing Market – Forecasts from 2016 to 2021
TO ORDER OR REQUEST FOR A SAMPLE: Product: Genetic Testing Market – Forecasts from 2016 to 2021 Link:https://www.knowledge-sourcing.com/products/genetic-testing-market-forecastsfrom-2016-to-2021 SKU: KSI0615309 Price: US$4,000 – Single User License US$6,000 – Multi User License US$8,000 – Enterprise License Payment: To pay by Credit Card, please, click “Add to Cart” button on product page and proceed with the payment For wire transfer, write to us at sales@knowledge-sourcing.com
For any custom requirements or queries, please visit our website or call us: Website: www.knowledge-sourcing.com Phone: +1-866-714-4587
Genetic Testing Market – Forecasts from 2016 to 2021